Arabic Arabic English English French French German German
dark

Hydroxychloroquine, mainstay lupus treatment, not associated with serious cardiac complication

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine, an antimalarial drug and mainstay therapy for lupus, does not appear to be associated with QTc interval prolongation, an irregularity of the electrical activity of the heart that places patients at risk for arrhythmias (irregular heartbeats). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

In COVID-19 vaccinated people, those with prior infection likely to have more antibodies

Next Post

Higher doses and longer use of hydroxychloroquine increase risk of severe eye complication

Related Posts
Total
0
Share